Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Research and Markets - United States Internal and External Radiation Therapy Devices Market Report 2016 Featuring Elekta, Varian Medical Systems, Theragenics, C.R. Bard, GE Oncura, Best Medical, IsoAid & IsoRay Medical

This image opens in the lightbox

News provided by

Research and Markets

23 Aug, 2016, 14:10 GMT

Share this article

Share toX

Share this article

Share toX

DUBLIN, August 23, 2016 /PRNewswire/ --

Research and Markets has announced the addition of the "US Market Report for Internal and External Radiation Therapy Devices" report to their offering.

Radiation therapy (RT) is a type of treatment most commonly used against cancer or to control and kill malignant cells. Typically, X-rays, gamma rays or charged particles (CPs) are the medium used. For oncological applications, RT works by attacking a cancerous cell's DNA. DNA (deoxyribonucleic acid), the molecules inside a cell that contain and pass along genetic data, is used in the development and operation of all known living organisms and certain viruses. RT works by damaging the DNA of cancerous cells, which leads to an inability for the targeted cells to grow. RT may be administered as either an adjunct or primary treatment therapy.

Key Topics Covered:

1. Executive Summary For Complete Report Suite

1.1 Market Overview

1.2 Competitive Landscape

1.3 Market Trends

1.4 Key Market Developments

1.5 Incidence Rates Included

1.6 Procedure Numbers

1.7 Markets Included

1.8 Key Report Updates

1.9 Version History

2. Research Methodology

2.1 Research Scope

2.2 9-Step Methodology

Step 1: Project Initiation & Team Selection

Step 2: Prepare Data Systems And Perform Secondary Research

Step 3: Preparation For Interviews & Questionnaire Design

Step 4: Performing Primary Research

Step 5: Research Analysis: Establishing Baseline Estimates

Step 6: Market Forecast And Analysis

Step 7: Identify Strategic Opportunities

Step 8: Final Review And Market Release

Step 9: Customer Feedback And Market Monitoring

3. Cancer Incidence Rates

3.1 Introduction

3.2 Cancer By Type

3.2.1 Genital Cancer

3.2.2 Digestive Cancer

3.2.3 Respiratory Cancer

3.2.4 Breast Cancer

3.2.5 Urinary Cancer

3.2.6 Skin Cancer

3.2.7 Lymphoma

3.2.8 Endocrine System Cancer

3.2.9 Leukemia

3.2.10 Oral Cavity/Larynx

3.2.11 Myeloma

3.2.12 Brain/Other Nervous System

3.2.13 Soft Tissue (Non-Heart)

3.2.14 Bones And Joints

3.2.15 Eye And Orbit

4. External Radiation Therapy Market

4.1 Introduction

4.1.1 External Radiation

4.1.1.1 External Radiation Therapy Device Types

4.1.1.1.1 Cobalt-60 Machines

4.1.1.1.2 Linear Particle Accelerators

4.1.1.1.3 Proton Therapy Machines

4.2 Market Overview

4.3 Market Analysis And Forecast

4.3.1 Total External Radiation Therapy Device Market

4.3.1.1 Linear Accelerator Device Market

4.3.1.2 Proton Therapy Device Market

4.3.2 Total External Radiation Therapy Device Maintenance Revenue

4.3.2.1 Linear Accelerator Maintenance Revenue

4.3.2.2 Proton Therapy Device Maintenance Revenue

4.4 Drivers And Limiters

4.4.1 Linear Accelerator Device Market

4.4.1.1 Market Drivers

4.4.1.2 Market Limiters

4.4.2 Proton Therapy Device Market

4.4.2.1 Market Drivers

4.4.2.2 Market Limiters

4.5 Competitive Analysis

4.5.1 Linear Accelerator Device Market

4.5.2 Proton Therapy Device Market

5. Internal Radiation Therapy Device Market

5.1 Introduction

5.1.1 Internal Radiation

5.1.1.1 Types Of Internal Radiation Therapy

5.1.1.1.1 Permanent Rti

5.1.1.1.2 Temporary Rti

5.1.1.2 Dose Rate

5.1.1.2.1 Low-Dose Rate (Ldr)

5.1.1.2.2 Medium-Dose Rate (Mdr)

5.1.1.2.3 High-Dose Rate (Hdr)

5.1.1.2.4 Pulsed-Dose Rate (Pdr)

5.1.1.3 Types Of Internal Radiation Therapy Sources

5.1.1.3.1 Ldr Sources

5.1.1.3.2 Hdr Sources

5.1.1.4 Afterloaders

5.2 Market Overview

5.3 Market Analysis And Forecast

5.3.1 Total Hdr Brachytherapy Market

5.3.1.1 Afterloader Market

5.3.1.2 Afterloader Service Market

5.3.2 Total Ldr Brachytherapy Market

5.3.2.1 Total Ldr Seed Market

5.3.2.1.1 Total Cesium-131 Seed Market

5.3.2.1.2 Total Paladium-103 Seed Market

5.3.2.1.3 Total Iodine-125 Seed Market

5.3.2.2 Ldr Needle Market

5.4 Drivers And Limiters

5.4.1 Market Drivers

5.4.2 Market Limiters

5.5 Competitive Analysis

Companies Mentioned

  • Elekta
  • Varian Medical Systems
  • Theragenics
  • C.R. Bard
  • GE Oncura
  • Best Medical
  • Eckert & Ziegler BEBIG
  • IsoAid
  • IsoRay Medical

For more information about this report visit http://www.researchandmarkets.com/research/mr695b/us_market_report

Related Topics: Medical Devices, Oncology Drugs , Radiography

Media Contact:

Research and Markets

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470

For U.S./CAN Toll Free Call +1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907

Fax (outside U.S.): +353-1-481-1716

Related Links

http://www.researchandmarkets.com

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.